Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature

Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature

Abstract Background Non-small cell lung cancer (NSCLC) represents more than about 80% of the lung cancer. The early stages of NSCLC can be treated with complete resection with a good prognosis. However, most cases are detected at late stage of the disease. The average survival rate of the patients w...

Full description

Bibliographic Details
Main Authors: Dan Li, William Yang, Yifan Zhang, Jack Y Yang, Renchu Guan, Dong Xu, Mary Qu Yang
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Medical Genomics
Subjects:
Adenocarcinoma in situ
AIS
Lung cancer
Invasive
Early diagnosis
lncRNAs
Online Access:http://link.springer.com/article/10.1186/s12920-018-0413-3

Internet

http://link.springer.com/article/10.1186/s12920-018-0413-3

Similar Items